Chr. Hansen is actively entering into partnerships with researchers and biotech companies with innovative projects within our specialized fields. Partnerships can start in all stages of a project – from joined research in the early discovery phases to in-licensing of fully developed products.

As a world leader within bacterial strains, we have the expertise throughout the value chain, from research to sales and support, and this enables us to offer a qualified partnership at all maturity stages of a project.

If an interesting strain has been identified, the development and clinical studies can be done in collaboration with the experts in our R&D departments.

We can also help with the formulation into different forms of dosage, such as capsules, application into final food products, the legal aspects and perhaps most importantly: Bringing the product to the market.